[{"address1": "200-3650 Gilmore Way", "city": "Burnaby", "state": "BC", "zip": "V5G 4W8", "country": "Canada", "phone": "604 484 3300", "fax": "604 484 3450", "website": "https://www.xenon-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.", "fullTimeEmployees": 316, "companyOfficers": [{"maxAge": 1, "name": "Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.", "age": 48, "title": "President, CEO & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 1184288, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 33.37, "open": 33.7, "dayLow": 33.055, "dayHigh": 33.83, "regularMarketPreviousClose": 33.37, "regularMarketOpen": 33.7, "regularMarketDayLow": 33.055, "regularMarketDayHigh": 33.83, "payoutRatio": 0.0, "beta": 1.097, "forwardPE": -9.342696, "volume": 492450, "regularMarketVolume": 492450, "averageVolume": 1302580, "averageVolume10days": 2230500, "averageDailyVolume10Day": 2230500, "bid": 33.17, "ask": 33.45, "bidSize": 10, "askSize": 10, "marketCap": 2552159488, "fiftyTwoWeekLow": 26.74, "fiftyTwoWeekHigh": 46.0, "priceToSalesTrailing12Months": 340.28793, "fiftyDayAverage": 32.7906, "twoHundredDayAverage": 37.397877, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1860807680, "profitMargins": 0.0, "floatShares": 70881895, "sharesOutstanding": 76733600, "sharesShort": 3690931, "sharesShortPriorMonth": 3470297, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0481, "heldPercentInsiders": 0.0014399999, "heldPercentInstitutions": 1.03509, "shortRatio": 2.87, "shortPercentOfFloat": 0.0537, "impliedSharesOutstanding": 76733600, "bookValue": 9.192, "priceToBook": 3.6183634, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -251446000, "trailingEps": -3.22, "forwardEps": -3.56, "enterpriseToRevenue": 248.108, "enterpriseToEbitda": -6.409, "52WeekChange": -0.10567355, "SandP52WeekChange": 0.12677538, "quoteType": "EQUITY", "currentPrice": 33.26, "targetHighPrice": 65.0, "targetLowPrice": 42.0, "targetMeanPrice": 55.23278, "targetMedianPrice": 55.0, "recommendationMean": 1.26316, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 18, "totalCash": 549628992, "totalCashPerShare": 7.163, "ebitda": -290361984, "totalDebt": 8675000, "quickRatio": 17.43, "currentRatio": 17.656, "totalRevenue": 7500000, "debtToEquity": 1.232, "revenuePerShare": 0.096, "returnOnAssets": -0.22032, "returnOnEquity": -0.31596002, "grossProfits": -219844000, "freeCashflow": -128485872, "operatingCashflow": -196854000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -9.6984005, "financialCurrency": "USD", "symbol": "XENE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NGM", "messageBoardId": "finmb_565718", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.329639, "regularMarketPrice": 33.26, "corporateActions": [], "postMarketTime": 1751567809, "regularMarketTime": 1751562000, "marketState": "CLOSED", "shortName": "Xenon Pharmaceuticals Inc.", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1415197800000, "postMarketChangePercent": 2.5856905, "postMarketPrice": 34.12, "postMarketChange": 0.8600006, "regularMarketChange": -0.110001, "regularMarketDayRange": "33.055 - 33.83", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1302580, "fiftyTwoWeekLowChange": 6.5199986, "fiftyTwoWeekLowChangePercent": 0.24382941, "fiftyTwoWeekRange": "26.74 - 46.0", "fiftyTwoWeekHighChange": -12.740002, "fiftyTwoWeekHighChangePercent": -0.27695656, "fiftyTwoWeekChangePercent": -10.567355, "earningsTimestamp": 1747080060, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754596800, "earningsCallTimestampStart": 1747081800, "earningsCallTimestampEnd": 1747081800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.22, "epsForward": -3.56, "epsCurrentYear": -4.0302, "priceEpsCurrentYear": -8.252692, "fiftyDayAverageChange": 0.4693985, "fiftyDayAverageChangePercent": 0.014315032, "twoHundredDayAverageChange": -4.1378784, "twoHundredDayAverageChangePercent": -0.11064474, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "longName": "Xenon Pharmaceuticals Inc.", "displayName": "Xenon Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-07-05"}]